Stopping GLP-1 therapy often leads to weight rebound Most practitioners report that discontinuing GLP-1 therapy results in significant weight regain
Moore also believes that slower, more sustainable weight loss allows the body more time to adjust to changes in weight, reducing the side-effect profile and potentially leading to better long-term success
Key effects include: Stimulation of collagen I, III, and V synthesis Increased elastin production Enhanced glycosaminoglycan (GAG) synthesis Promotion of blood vessel growth (angiogenesis) Anti-inflammatory gene modulation Superoxide dismutase upregulation (antioxidant protection) Hair follicle enlargement and growth stimulation How Semaglutide in This Context Semaglutide is a GLP-1 receptor agonist that produces weight loss primarily through appetite suppression and improved metabolic function
Thirdly, given the observational nature of our study, it is not possible to determine whether observed changes in levels of metabolites reflect changes in dietary patterns, nutrient absorption, catabolism, or flux
Retatrutide is an investigational triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, enhancing insulin secretion, suppressing appetite, and potentially increasing energy expenditure
